| Heather Bodiford Bartels, MD | |
|
454 Old Street Rd Ste 204, Peterborough, NH 03458-1200 | |
| (603) 668-2020 | |
| (603) 668-0881 |
| Full Name | Heather Bodiford Bartels |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 8 Years |
| Location | 454 Old Street Rd Ste 204, Peterborough, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386098648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 23535 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monadnock Community Hospital | Peterborough, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Medical Eye Center Pc | 7315916095 | 9 |
News Archive
TGen Drug Development (TD2) and Critical Outcome Technologies Inc. (COTI) (TSXV:COT) announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug called COTI-2.
One in five Americans have allergic rhinitis, a number that is steadily rising, but the exact reasons for this increase are unknown. A new lipid-based nasal ointment is found effective at reducing symptoms of allergic rhinitis in German patients.
A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF) and published in Nature Biotechnology.
WHO has issued its first guidance to countries that are considering offering HIV medications, known as antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection.
› Verified 9 days ago
| Entity Name | The Medical Eye Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225004955 PECOS PAC ID: 7315916095 Enrollment ID: O20040929000647 |
News Archive
TGen Drug Development (TD2) and Critical Outcome Technologies Inc. (COTI) (TSXV:COT) announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug called COTI-2.
One in five Americans have allergic rhinitis, a number that is steadily rising, but the exact reasons for this increase are unknown. A new lipid-based nasal ointment is found effective at reducing symptoms of allergic rhinitis in German patients.
A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF) and published in Nature Biotechnology.
WHO has issued its first guidance to countries that are considering offering HIV medications, known as antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Bodiford Bartels, MD 250 River Rd, Manchester, NH 03104-2423 Ph: (603) 668-2020 | Heather Bodiford Bartels, MD 454 Old Street Rd Ste 204, Peterborough, NH 03458-1200 Ph: (603) 668-2020 |
News Archive
TGen Drug Development (TD2) and Critical Outcome Technologies Inc. (COTI) (TSXV:COT) announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug called COTI-2.
One in five Americans have allergic rhinitis, a number that is steadily rising, but the exact reasons for this increase are unknown. A new lipid-based nasal ointment is found effective at reducing symptoms of allergic rhinitis in German patients.
A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF) and published in Nature Biotechnology.
WHO has issued its first guidance to countries that are considering offering HIV medications, known as antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection.
› Verified 9 days ago
Theodore Renna, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 454 Old Street Rd, Suite 204, Peterborough, NH 03458 Phone: 603-924-7070 Fax: 603-924-6700 | |
Gladys Lee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 454 Old Street Rd, Suite 204, Peterborough, NH 03458 Phone: 603-924-7070 Fax: 603-924-6700 |